Home >> Tag Archives: Danaher—

Tag Archives: Danaher—

Danaher to acquire Phenomenex

Oct. 24, 2016—Phenomenex, a privately held manufacturer and distributor of chromatography consumables serving the liquid and gas chromatography market, has signed a definitive agreement to be acquired by Danaher. Phenomenex will operate as a standalone operating company, retaining its brand, personnel, and site locations. Phenomenex has more than 7,000 products supporting a broad diversity of applications in drug discovery and ...

Read More »

Danaher buys Cepheid for $4 billion

Sept. 6, 2016—Danaher has entered into a definitive merger agreement with Cepheid pursuant to which Danaher will acquire all of the outstanding shares of Cepheid for $53 per share in cash, or a total enterprise value of about $4 billion including indebtedness and net of acquired cash. “We expect Cepheid to be an excellent complement to our existing diagnostics businesses ...

Read More »

Danaher to separate into two businesses, 6/15

June 2015—Danaher Corp. will separate into two independent, publicly traded companies. The transaction will create a science and technology growth company that will retain the Danaher name. Collectively, its businesses generated approximately $16.5 billion in revenues (including Pall Corp., which Danaher has signed an agreement to acquire) in their most recently completed fiscal years.

Read More »

Danaher will split into two companies

May 28, 2015—Danaher Corp. announced recently its intention to separate the company into two independent, publicly traded companies. One company will retain the Danaher name and businesses that have generated about $16.5 billion in revenue. The other company will be dubbed NewCo and keep brand names and businesses that have generated about $6 billion in the last complete fiscal year, ...

Read More »